Cultivating Growth: Unraveling the Microbial API Market
The Microbial API Market is experiencing a significant surge driven by the increasing demand for pharmaceutical ingredients derived from microbial sources and the growing prevalence of infectious diseases. Key takeaways from the market underscore the pivotal role of microbial active pharmaceutical ingredients (APIs) in the development of novel therapeutics and the expansion of treatment options.
The global microbial API market size is expected to reach US$ 96.11 Bn by 2031, from US$ 61.21 Bn in 2024, at a CAGR of 6.7% during the forecast period.